Pink Sheet

New EU Approvals

02 Feb 2021

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include seven new products, including the COVID-19 vaccines from AstraZeneca/Oxford University and Moderna respectively. The list, which contains information dating back to January 2018, comprises brand name, generic name, company, therapeutic indication, date of marketing authorization announcement and product type (eg, medicine, vaccine, biologic).

The Pink Sheet’s regularly updated list of products containing new active substances that have been approved for marketing in the EU under the centralized authorization procedure now includes seven new products – COVID-19 Vaccine AstraZeneca, Enhertu, Elzonris, Xofluza , COVID-19 Vaccine Moderna, Libmeldy, and Tecartus.

The great majority of new, innovative medicines and vaccines that are marketed in the EU go through the centralized procedure....